GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming TD Cowen 45th Annual Health Care Conference, being held in Boston, MA.TD Cowen 45th Annual ...Full story available on Benzinga.com
Senseonics is a Maryland-based medical device firm that develops, and markets implantable continuous glucose monitoring systems for the treatment of patients with diabetes.